Tamara Miller

21 papers receiving 945 citations

Tamara Miller's Hit Papers

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial 2012 · 891 citations
8910+4+9Years since publication250500750

Peers

Tamara Miller
Comparison fields: 5 of 59
  • Pathology and Forensic Medicine 764
  • Neurology 214
  • Immunology 191
  • Rheumatology 128
  • Oncology 198
Replace M. Stojanovic with:
M. Stojanovic Serbia
Bella Ertik United States
Pedro Oyuela United States
Anthony Hamlett United States
Karthinathan Thangavelu United States
Pierangelo Barbero Italy
T. Pickersgill United Kingdom
H.-F. Petereit Germany
N. А. Totolyan Russia
Florence Casset‐Semanaz Switzerland
Tamara Miller relative to M. Stojanovic Serbia M. Stojanovic's profile →
Citations per field
00.5×1.5×
M. Stojanovic · 1×
Citations per year

Countries citing papers authored by Tamara Miller

Since Specialization
Citations

This map shows the geographic impact of Tamara Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamara Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamara Miller more than expected).

Fields of papers citing papers by Tamara Miller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamara Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamara Miller. The network helps show where Tamara Miller may publish in the future.

Co-authors

The 25 scholars most cited alongside Tamara Miller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tamara Miller Line = papers co-authored together Tamara Miller links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
Hit paper breakdown →
2012891
2 201214
3 20208
4 20196
5 20226
6 20206
7 20125
8 20125
9 20134
10 20133
11 20213
12 20132
13 20042
14 20192
15 20132
16 20131
17 20131
18 20131
19 20191
20 20131

About Tamara Miller

Tamara Miller is a scholar working on Pathology and Forensic Medicine, Oncology, Immunology, Molecular Biology and Neurology, having authored 22 papers that have together received 965 indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (17 papers), Polyomavirus and related diseases (5 papers), Acute Lymphoblastic Leukemia research (2 papers), Immunotherapy and Immune Responses (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers), 14-3-3 protein interactions (2 papers), Rheumatoid Arthritis Research and Therapies (2 papers) and Peripheral Neuropathies and Disorders (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (764 citations), Neurology (214 citations), Immunology (191 citations), Rheumatology (128 citations) and Oncology (198 citations). Tamara Miller has collaborated with scholars based in United States, Canada and Czechia. Frequent co-authors include Cary Twyman, Krzysztof Selmaj, Stephen Lake, Christian Confavreux, Edward Fox, Alasdair Coles, Jeffrey Cohen, Douglas L. Arnold, David Margolin and Eva Havrdová. Their work appears in journals such as Neurology, Multiple Sclerosis and Related Disorders, International Journal of MS Care, The Lancet and Frontiers in Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact